Biomaterial Database

The effectiveness of malaria camps as part of the malaria control program in Odisha, India. 2023

Danielle C Ompad, and Timir K Padhan, and Anne Kessler, and Stuti Mohanty, and Yesim Tozan, and Abbey M Jones, and Anna Maria van Eijk, and Steven A Sullivan, and Mohammed A Haque, and Madan Mohan Pradhan, and Sanjib Mohanty, and Jane M Carlton, and Praveen K Sahu

School of Global Public Health, New York University, New York, NY, 10003, USA.

Durgama Anchalare Malaria Nirakaran (DAMaN) is a multi-component malaria intervention for hard-to-reach villages in Odisha, India. The main component, Malaria Camps (MCs), consists of mass screening, treatment, education, and intensified vector control. We evaluated MC effectiveness using a quasi-experimental cluster-assigned stepped-wedge study with a pretest-posttest control group in 15 villages: six immediate (Arm A), six delayed (Arm B), and three previous interventions (Arm C). The primary outcome was PCR+ Plasmodium infection prevalence. Across all arms, the odds of PCR+ malaria were 54% lower at the third follow-up compared to baseline. A time (i.e., visit) x study arm interaction revealed significantly lower odds of PCR+ malaria in Arm A versus B at the third follow-up. The cost per person ranged between US$3-8, the cost per tested US$4-7, and the cost per treated US$82-1,614, per camp round. These results suggest that the DAMaN intervention is a promising, financially feasible approach for malaria control.